摘要
药品上市后风险管理是全世界各国药品管理部门面临的严峻挑战。通过对加拿大药品上市后管理部门机构设置、职能及特点的阐述与分析,为我国药品上市后风险管理提供参考。
The risk management of drug is a big challenge for the drug regulatory authorities all over the world. Through the description of the functions of the Canadian Marketed Health Products Directorate （MHPD） and the analysis of its characteristics, to provide reference for drug risk management of China.
出处
《中国药物警戒》
2009年第1期4-7,共4页
Chinese Journal of Pharmacovigilance
关键词
药品
风险管理
工作程序
沟通
drug
risk management
procedure
communication
